Background Many volatile organic compounds (VOCs), principally alkanes and benzene
derivatives, have been identified in breath from patients with lung cancer. We investigated …

This paper outlines the design and performance of an observational study on the profiles of
volatile organic compounds (VOCs) in the breath of 37 lung cancer patients and 23 healthy …

Study objectives To evaluate volatile organic compounds (VOCs) in the breath as tumor
markers in lung cancer. Alkanes and monomethylated alkanes are oxidative stress products …

Early diagnosis of lung cancer results in improved survival compared to diagnosis with more
advanced disease. Early disease is not reliably indicated by symptoms. Because …

Due to state-of-art analytical techniques, non-invasive exhaled volatile organic compounds
(VOCs) analysis has become a potential method for early diagnosis of lung cancer. We …

One of the main causes of the high mortality rate in lung cancer is the late-stage tumor
detection. Early diagnosis is therefore essential to increase the chances of obtaining an …

Background: Normal metabolism generates several volatile organic compounds (VOCs) that
are excreted in the breath (eg alkanes). In patients with lung cancer, induction of high-risk …

Background Non-invasive diagnostic strategies aimed at identifying biomarkers of lung
cancer are of great interest for early cancer detection. The aim of this study was to set up a …

Breath analysis for the purpose of non-invasive diagnosis of lung cancer has yielded
numerous candidate compounds with still questionable clinical relevance. To arrive at …

BACKGROUND. The specific volatile organic compounds (VOCs) exhaled by lung cancer
cells in the microenvironment are the source biomarkers of lung cancer and also serve as …